News

2024/02/22

Medivir presents data that strengthens the fostrox/Lenvima combination in primary liver cancer at EASL Liver Cancer Summit

Read more
2024/02/15

MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2023

Read more
2024/01/31

Number of shares and votes in Medivir AB on 31 January 2024

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.